|Duration: 1.5 hours (the average time to complete the training program, including final assessments).
Credit Hours: See individual courses for credit hours assigned.
Self-paced Training: 24/7 access to course.
Enrollment Period: 6 months.
Demonstration: Try one of our FREE courses.
Certificate: View sample certificate.
THIS COURSE IS CURRENTLY NOT AVAILABLE.
Contact the BioPharma Institute for more information.
Description: Glaucoma is a leading cause of irreversible vision loss, second only to cataracts as the most common cause of blindness. Glaucoma affects about 70 million people worldwide, over 6.7 million of whom are bilaterally blind. As the American population ages, the risk of developing glaucoma is rapidly increasing. By the year 2020, glaucoma is projected to affect 3.4 million people. Several types of glaucoma exist, and there is much debate about their classification. There are open angle glaucomas without other known ocular or systemic disorders, angle closure glaucomas without other known ocular or systemic disorders, developmental or congenital glaucomas, and glaucomas associated with other ocular and systemic disorders (disorders of the retina, choroid, or vitreous, intraocular tumors, inflammation, steroid-induced disorders, trauma, hemorrhage, iatrogenic disorders, and postoperative disorders). This suite discusses the pathophysiology and epidemiology of various types of glaucoma, as well as common diagnostic tests and the currently available pharmacological and surgical treatment options.
Training Provided By: BioPharma Institute
The Glaucoma: Three-Course Suite includes these individual courses:
Online Training Programs Include:
For more information on the BioPharma Institute’s training programs, or to suggest a course, please complete the form located below. Alternatively, you may call toll free in the US: (888) 4-BIO-LRN, international callers can dial (201) 301-8370, or email Support@BioPharmaInstitute.com.